Dear members,
On behalf of the GMP Board and Scientific Committee, it is our great pleasure to share with you the program of the 37h GMP Symposium.

We hope to see you there with the exciting scientific and social programs.

This symposium fees are as follow (actualized price appears on the left hand-side when you are logged in, membership fees not included):

• Satellite sessions: free (members only)
• Gala dinner: 50 euros
• Symposium:
  • Early Bird (up to July, 31st 2025):
    • Student members WITH poster: 50 euros (Gala dinner included, see abstract guidelines for contacts and application before getting your tickets)
    • Student members WITHOUT poster: 375 euros
    • Academic members: 375 euros
    • Industrial members: 750 euros
  • Standard (after July, 31st 2025):
    • Student members WITH poster: 50 euros (Gala dinner included, see abstract guidelines for contacts and application before getting your tickets)
    • Student members WITHOUT poster: 425 euros
    • Academic members:425 euros
    • Industrial members: 850 euros

Warm regards,

The GMP Board

37th GMP SYMPOSIUM
PRELIMINARY PROGRAM

Day 1 – 15th Oct 2025

09.30 – 12:30

Workshops (free for members, needs to be booked separately, first come-first served basis):

GMP Satellite session 1: Coming soon

GMP satellite session 2: Coming soon

12.30 – 13:30

Arrival and Registration
Welcome Coffee/Tea

13:30 – 13:40

Welcome to 2024 GMP Symposium

Session 1

Replacing and refining in vivo pharmacokinetic experiments

Chairs: C. Amara (Sanofi), F. Gattacceca (COMPO, CRCM, Aix-Marseille university)

This session will explore strategies to replace living animals with virtual equivalents, with more human-relevant in-vitro methods, but also to develop innovative bioanalycal techniques to increase the sensitivity of quantification of protein drugs in plasma and tissues.

1- Vict3R consortium : Coming soon

2- M. Dupré (Sanofi): Coming soon  

Session 2

New modalities of drug administration 

Chairs: S. Klieber (Sanofi), L. Laplanche (Abbvie), C. Troisi (EsQlabs)

Join us to learn more about how to overcome PK challenge of new modalities ((e.g., LNP, radiopharmaceuticals, PROTACs) and how these innovations collectively aim to improve patient outcomes and expand the therapeutic landscape.

1- S. Guerif (Sanofi): Coming soon

2- Z. Fang (Merck Healthcare KGaA): Coming soon

3- Q. Nguyen (Novartis): Coming soon

Coffee Break and Poster Session

Session 3

New biomarkers for translational studies 

Chairs: E. Chatelut (Oncopole-Toulouse University), N. Perdaems (Syneos Health), A. Martinez (Toulouse university)

Biomarkers and PK are complementary to understand mechanism of action and adverse effects of biologics. Moreover, use of biomarkers dynamics and PK could significantly reduce the large delay between treatment onset and response. The relation between early biomarker dynamics and anticancer drug PK can be used to individualize anticancer treatment.

1- N. Van Erp (Radboud University Medical Center): Coming soon

2- A. Delmas (Laboratoires Servier): Coming soon

Students Poster Blitz

Chairs: Coming soon

We welcome student abstracts in the field of pharmacology (ADME, PK, PD, PBPK,  DDI). All submitted abstracts will be reviewed by the selection committee and chosen  to be part of a poster presentation and short-oral presentation. A “Best Student  presentation” awards will be announced during the GMP Congress 2025. 

The program is open to all students at the Undergraduate, Masters, and Doctoral levels. Presenters must be present during the congress.

Poster Session & Cocktail

Day 2 – 16th Oct 2025

8.00 – 8.30

Welcome Coffee/Tea

Key Note Speaker: P. Moingeon (Paris-Saclay University)

Intelligent drugs: how AI is transforming healthcare

Chair: C. Amara, M. Coimbra (Sanofi)

Coffee Break and Poster Session

Session 4

Artificial Intelligence and Machine Learning shaping the Future of Drug Development

Chairs: O. Nicolas (Sanofi), F. Gattacceca (COMPO, CRCM, Aix-Marseille university), M. Coimbra (Sanofi)

This session is intended to provide insights on how Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing the pharmaceutical industry. PhD students and industrial experts will present some latest advancements and practical applications in AI-driven drug discovery & development shaping the future of healthcare

1 – M. Karlsen (Sanofi): Coming soon

2- N. Canouï (Aqemia): Coming soon

3- M. Boussena (COMPO, CRCM, Aix-Marseille    university): Coming soon

GMP Assemblée Générale

Lunch & Posters

Session 5

Beyond a Covariate: Towards Sex-Based

Chairs: F. Gallais (Pharmetheus), A. Puszkiel (Cochin University Hospital), C. Troisi (ESQlabs), M. Le Merdy (Simulations Plus)

This session explores the critical need to move beyond treating sex as a simple covariate in drug development for women. We will discuss the differences in drug response between sexes, the considerations for drug use during pregnancy and lactation, and the importance of studying sex differences to create more effective and safer medications for women.

1 – P. Annaert (KU Leuven): Coming soon

2- E. Hansson (Pharmetheus): Coming soon

3- J. Delahousse (Gustave Roussy) : Coming soon

Coffee Break and Poster Session

Session 6

Innovations in Drug Transporters                                                                                                     

Chairs: M. De Sousa Mendes (Certara), O. Nicolas (Sanofi)

Discover the latest advancements in drug transport in this captivating session. We will explore how albumin-mediated drug uptake via organic anion transporters is a reality, and its implications for predicting active renal secretion clearance. Additionally, we will examine the crucial role of pre-incubation in these processes and discuss current and future regulatory perspectives. Join us for an in-depth and interactive discussion on these innovations that could support pharmacokinetic predictions and improve drug developments

1 – S. Neuhoff (Certara): Coming soon

2- P. Tatrai (Solvo): Coming soon

3-D. Scotcher (University of Manchester): Coming soon

One Step Aside

Médicament et philosophie

Chairs: E. Chatelut (Oncopole-Toulouse University), I. Deprez (Certara)
In this presentation, we will explore the current and potential roles of AI in drug R&D and how it redefines the way scientists integrate data generation with technological applications and wet-lab validation. We will deep-dive into the scientific implications, impacts on researchers, and the research process itself. A key question we will address is whether AI represents merely another tool or signifies a more profound shift in scientific inquiry.  

1- Nicolas Martin (former pharmacy intern and journalist at France Culture)

Gala Dinner (please do not forget to get your additional ticket tickets)

Day 3 – 17th Oct 2024

8.30 – 9.00

Welcome Coffee/Tea

Session 7

Dose individualization

Chairs: Chatelut (Oncopole-Toulouse University), A. Puszkiel (Cochin University Hospital), M. Le Merdy (Simulations Plus)

Dose individualization will be addressed in several populations, for different drugs, objectives and circumstances: adults vs. children, small molecules vs. biologics, therapeutic vs. financial issues, pre- vs. post-registration.

1 – D.J.A.R. Moes (University of Leiden): Coming soon

2- F. Foissac (University of Paris Cité): Coming soon

3- F. Lemaitre (University of Rennes): Coming soon

Coffee Break

Session 8

Central nervous system and therapy

Chairs: S. Lobet (Calvagone), N. Perdaems (Syneos Health), C. Troisi (ESQlabs)

This session explores innovative strategies to overcome the challenges of delivering therapeutics to the central nervous system (CNS). Topics include Brain shuttle™, a cutting-edge platform enabling the transport of large-molecule drugs across the blood-brain barrier with clinical PK/PD considerations, and BEPO®, a long-acting injectable technology designed for sustained treatment of CNS disorders.

1 – N. Janssen (Roche): Coming soon

2- A. Lopez-Noriega (Medincell): Coming soon

3- Coming soon

Poster Awards

Closing Remarks

Farewell Lunch

Hotel Reservation

Coming soon